ZEB1 and central nervous system cancer: Results of univariate Cox regression analysis revealed that both ZEB1-AS1 overexpression (HR = 2.119, 95% CI: 1.265–3.551, p = 0.004) and the clinical stage (HR = 2.141, 95% CI: 1.286–3.563, p = 0.003) were prime variables for glioma prognosis (Table 2).